Montelukast Prescribing at ROSEBANK SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
5,136
Total Quantity
144.1K
NHS Cost
£6.9K
vs National Avg
+650.1%
ROSEBANK SURGERY prescribed 5,136 items of Montelukast over the last 12 months at a cost of £6,908 to the NHS. This is 650.1% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
429
Jul 2026
479
Jul 2026
426
Jul 2026
421
Jul 2026
436
Jul 2026
420
Jul 2026
439
Jul 2026
456
Jul 2026
438
Jul 2026
403
Jul 2026
405
Jul 2026
384
Prescribing Details
| Total Items | 5,136 |
|---|---|
| Total Quantity | 144,099 |
| Total NHS Cost | £6,908 |
| Presentations | 4 different forms |
| vs National Average | +650.1% |
Montelukast Prescribing Comparison
| This practice | 5,136 items |
|---|---|
| National average per practice | 685 items |
| Difference | +650.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.